5 AI Funding Weekly Highlights | 12.2-12.8
Explore the latest AI funding insights, from MetaNovas’ ingredient innovation to Yurts’ secure AI platforms, totaling millions in global investment.
This week, there were five AI-related funding projects.
These projects range from several million to tens of millions of dollars in funding.
MetaNovas｜Series A｜Undisclosed
MetaNovas Biotech recently completed a Series A funding round led by GL Ventures and Baoding Ventures, with participation from publicly listed company Ruoyuchen. Moomian Capital acted as the exclusive financial advisor for this round.
Founded in early 2021 in Silicon Valley and Shanghai, MetaNovas specializes in AI-driven discovery and manufacturing of new ingredients for consumer health. Utilizing AI combined with a billion-scale knowledge graph, the company focuses on developing functional peptides and other high-performance materials and formulations.
The founding team has expertise spanning AI, bioinformatics, and biopharmaceuticals. The biopharma team comes from leading AI pharmaceutical companies, while the AI engineering and business operations team includes talent from MIT, Yale, Stanford, NVIDIA, and Amazon.
MetaNovas collaborates with leading global consumer goods and cosmetics companies to provide innovative ingredient development and product solutions, leveraging its AI technology platform to expand its international client base.